Since July 1, 2023, the Belgian and Luxembourg "National Medicines Verification System" (#NMVS) has been connected to the "European Alert Management System" (#EAMS) through a "National Alert Management System" (#NAMS). 🔗 A real-time processing of the EU-FMD alerts in the software of pharmacies and wholesalers is now possible, and the Belgian and Luxembourg NCAs (FAGG -AFMPS + DPM) have therefore decided to switch to a full implementation of the EU-FMD before the end of 2023. ⌛ Given the major impact of this measure, we strongly encourage you to register for this informative #webinar and find out what is expected of the MAH and its OBP. 👇 https://hubs.li/Q020NQ1P0 #medicine #pharma #FMD #EUFMD

Have you heard about the restructure of the Agenzia Italiana del Farmaco (AIFA) in Italy? The Comitato Tecnico Scientifico (CTS) and the Comitato Prezzi e Rimborso (CPR) are merging into a single body: the Commissione Scientifica ed Economica (CSE). The structural changes to the AIFA are anticipated to increase efficiencies during the reimbursement processes. Access this and more insights in the new 2023/24 edition of our guide: 'Market access and reimbursement in key European markets'. Request your free copy at: https://lnkd.in/eznsBfUW #marketaccess #Europe #Italy #AIFA #HTA #reimbursement

I will be speaking at the World Drug Safety Congress Europe at Amsterdam on 4th October. Will discuss ways to mitigate risk and enhance patient safety through addressing current challenges in signal management. Significance of Real-world data in signal detection. Learn more and connect with our team if you’ll be in Amsterdam for the meeting! #PatientSafety, #Pharmacovigilance, #DrugSafety, #SignalDetection, #RiskManagement, #RealWorldData, #Parexel, #WDSC.

Have you heard about the restructure of the Agenzia Italiana del Farmaco (AIFA) in Italy? The Comitato Tecnico Scientifico (CTS) and the Comitato Prezzi e Rimborso (CPR) are merging into a single body: the Commissione Scientifica ed Economica (CSE). The structural changes to the AIFA are anticipated to increase efficiencies during the reimbursement processes. Access this and more insights in the new 2023/24 edition of our guide: 'Market access and reimbursement in key European markets'. Request your free copy at: https://lnkd.in/ecVuTGM2 #marketaccess #Europe #Italy #AIFA #HTA #reimbursement

BREAKING: CADTH have announced a new Target Zero initiative that aims to shorten the time to patient access for new cost-effective drugs. 0️⃣ The ambitious goal of Target Zero is to achieve zero days between Health Canada’s regulatory approval of a drug and CADTH’s reimbursement recommendation to participating public drug plans. 🛣️ The roadmap includes significantly increasing collaboration, coordination and information sharing within the drug review process, along with leveraging the creation of the new Canadian Drug Agency (CDA). 📰 Find out more at: https://buff.ly/3JaKbCP #CADTH #HTA #marketaccess #canada #healthcanada #healthtechnologyassessment #targetzero #drugs #reimbursement #costeffectiveness #tuesdaythoughts